Monosodium neridronate is an amino-containing bisphosphonate bone resorption inhibitor. Binding with high affinity to hydroxyapatite surfaces, it induces osteoclast apoptosis by strongly inhibiting farnesyl pyrophosphate synthase (FPPS) activity, demonstrating outstanding efficacy in models of osteogenesis imperfecta and Pagets disease.
Molecular Weight:
299.13
Purity:
99.95%
CAS Number:
[80729-79-9]
Formula:
C6H16NNaO7P2
Target:
Others
T212779
* VAT and and shipping costs not included. Errors and price changes excepted